News
59m
Flow Space on MSNLizzo's Weight Loss Reveal Sparks Key GLP-1 Advice
For example, on a recent episode of the Just Trish podcast, singer, songwriter and rapper Lizzo explained that she tried ...
For older adults with type 2 diabetes, glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with ...
Linda Yaccarino is taking the top job at eMed Population Health, a telehealth startup focused on GLP-1 weight loss drugs, ...
Dr. Tim Church predicted recently that GLP-1 agonists, GLP-1 /GIP agonists and similar prescription drugs will soon be as ...
Novo Nordisk remains a strong buy despite share price dip, thanks to its robust drug pipeline, massive market potential, and ...
1d
MedPage Today on MSNNearly 17M U.S. Teens, Young Adults Eligible for GLP-1 Agonists
Though an estimated 17 million U.S. adolescents and young adults were eligible for GLP-1 receptor agonists for conditions ...
4h
FOX61 on MSNSettlement reached in lawsuit alleging sales of 'bootleg' GLP-1s without prescriptions
Triggered Brand has agreed to pay $18,500 out of a $300,000 judgment after Attorney General William Tong sued the company in ...
GLP-1s are bringing many changes to people's lives. An unexpected and less welcome one? A newfound aversion to meat and other ...
Hims & Hers Health, Inc.'s core growth and product diversification signal long-term potential, despite short-term dips. Click ...
8h
Zacks.com on MSNWill GLP-1 Demand Drive MCK's Top Line This Earnings Season?
MCK's Q1 results are expected to reflect strong prescription volume growth from GLP-1 demand, but lower margins may weigh on profitability.
Explore how GLP-1a drugs transform the food industry from a threat to an opportunity. Our 36-page strategy briefing outlines the potential for growth by meeting the rising demand for protein, fiber, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results